METASTASTIC BREAST CANCER

Clinical trials for METASTASTIC BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new METASTASTIC BREAST CANCER trials appear

Sign up with your email to follow new studies for METASTASTIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a Triple-Drug combo keep advanced breast cancer in check?

Disease control Recruiting now

This phase II trial is testing whether adding a new oral drug called culmerciclib to standard anti-HER2 therapy and hormone therapy can help maintain control of advanced breast cancer that is both hormone receptor-positive and HER2-positive. The study enrolls women with metastati…

Matched conditions: METASTASTIC BREAST CANCER

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC

METASTASTIC BREAST CANCER

Get alerted when new METASTASTIC BREAST CANCER trials appear

Can a Triple-Drug combo keep advanced breast cancer in check?